Answer
Comirnaty LP.8.1 carries a warning of increased myocarditis and pericarditis risk following Comirnaty vaccination, primarily within 14 days and more often after the second vaccination and in younger males; most cases recover, but some require intensive care and fatal cases have occurred.
Sources for this answer
- Comirnaty LP.8.1 30 microgram/dose dispersion for injection in pre-filled syringeBioNTech - Pfizer · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked